SODIUM NITROPRUSSIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sodium nitroprusside and what is the scope of freedom to operate?
Sodium nitroprusside
is the generic ingredient in four branded drugs marketed by Roche, Abbott, Abbvie, Hospira, Vpna, Abraxis Pharm, Amneal, Amphastar Pharms Inc, Avet Lifesciences, Baxter Hlthcare, Be Pharms, Caplin, Chartwell Rx, Cipla, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Hainan Poly Pharm, Micro Labs, Mylan Labs Ltd, Nexus, Norvium Bioscience, Sagent Pharms Inc, Somerset Theraps Llc, Sun Pharm, Teva Parenteral, Xiromed, Exela Pharma, and Hainan Poly, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.There are fourteen drug master file entries for sodium nitroprusside. Sixteen suppliers are listed for this compound.
Summary for SODIUM NITROPRUSSIDE
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 29 |
NDAs: | 29 |
Drug Master File Entries: | 14 |
Finished Product Suppliers / Packagers: | 16 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Clinical Trials: | 76 |
Patent Applications: | 95 |
Drug Prices: | Drug price trends for SODIUM NITROPRUSSIDE |
What excipients (inactive ingredients) are in SODIUM NITROPRUSSIDE? | SODIUM NITROPRUSSIDE excipients list |
DailyMed Link: | SODIUM NITROPRUSSIDE at DailyMed |
Recent Clinical Trials for SODIUM NITROPRUSSIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Egymedicalpedia | Early Phase 1 |
Tanta University | N/A |
Kafrelsheikh University | N/A |
Pharmacology for SODIUM NITROPRUSSIDE
Drug Class | Vasodilator |
Physiological Effect | Vasodilation |
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM NITROPRUSSIDE
US Patents and Regulatory Information for SODIUM NITROPRUSSIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cipla | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 210855-001 | Jul 16, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma Llc | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 208635-001 | May 4, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hainan Poly | SODIUM NITROPRUSSIDE | sodium nitroprusside | SOLUTION;INTRAVENOUS | 215846-003 | Aug 26, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sagent Pharms Inc | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 207426-001 | Dec 8, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Avet Lifesciences | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 208923-001 | Nov 8, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Parenteral | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 073465-001 | Mar 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.